Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods

Thromb Res. 2001 May 15;102(4):311-7. doi: 10.1016/s0049-3848(01)00259-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Abciximab
  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Blood Platelets / drug effects
  • Blood Platelets / physiology*
  • Carotid Stenosis / therapy*
  • Female
  • Flow Cytometry / methods
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage
  • Immunoglobulin Fab Fragments / therapeutic use*
  • In Vitro Techniques
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Aggregation* / drug effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Recurrence
  • Stents*
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab